Mörsdorf K, Wolf G
Arzneimittelforschung. 1977;27(3):531-3.
In a comparative study new antiinflammatory agents, like sodium-(3-[(2,6-dichlorephenyl)-amino5-phenyl)-acetate (diclofenac); d,l-2-(3-phen0xy-phenyl) propionic acid (fenoprofen); 2-(3-benzoxyl-phenly-propionic acid (ketoprofen); cis-5-fluoro-2-methyl-1-(p-methylsulfinyl) benzylideryl-3-indenyl-acetic acid (MK 231, sulindac); 2-(6-methoxy-2-naphthyl)-propionic acid (naproxen/, showed nearly the same antiiflammatory effectiveness as 5-methoxy-2-methyl-1-(4-chlorobenzoyl)-indolyl-(3)-acetic acid (indometacin). In homogenates of inflamed rat paws an antiproteolytic activity of the new antiinflammatory agents was lacking.
在一项比较研究中，新型抗炎药，如（3-[(2,6-二氯苯基)-氨基-5-苯基]乙酸钠（双氯芬酸）；d,l-2-(3-苯氧基苯基)丙酸（非诺洛芬）；2-(3-苯并氧基苯基)丙酸（酮洛芬）；顺式-5-氟-2-甲基-1-(对甲基亚磺酰基)苄叉基-3-茚基乙酸（MK 231，舒林酸）；2-(6-甲氧基-2-萘基)丙酸（萘普生），显示出与5-甲氧基-2-甲基-1-(4-氯苯甲酰基)-吲哚-3-乙酸（吲哚美辛）几乎相同的抗炎效果。在炎症大鼠爪的匀浆中，新型抗炎药缺乏抗蛋白水解活性。
